Compositions for interferon blockade and methods of using same
AssigneeChildren's Hospital Medical Center
InventorSonata Jodele
Life of this patent
Estimating the term…
Abstract
Disclosed are compositions that may include one or more inhibitors of interferon activity for the treatment of a disease state, for example, a disorder associated with increased interferon levels such as thrombotic microangiopathy (“TMA”). Also disclosed are methods of treating an individual having a disease state such as thrombotic microangiopathy. Further disclosed are methods of diagnosing an individual with TMA.
Claims18
1-7. (canceled)
A method of treating an individual having TMA, comprising the step of administering emapalumab to said individual.
(canceled)
A method of treating an individual suspected of having a disorder associated with increased interferon levels, comprising the steps of
- a. detecting a level of a marker selected from an interferon or a interferon gamma induced chemokine, or wherein said interferon gamma induced chemokine is selected from CXCL9, CXCL10, CXCL11, or combinations thereof;
- b. administering an interferon blocker to said individual when said blood level is increased as compared to a predetermined level.
A method of diagnosing an individual with TMA, comprising the step of detecting IFNγ, CXCL9, CXCL10, CXCL11, or a combination thereof, wherein when said level of IFNγ, CXCL9, CXCL10, CXCL11, or combination thereof is increased compared to a control value, said individual is diagnosed with a disorder selected from TMA, preferably TMA associated with or secondary to a disease or condition selected from post-organ transplant, pregnancy, severe inflammation, cytokine storm syndrome (CRS) due to chimeric antigen receptor T cell (CART) therapy, solid organ transplant, rheumatologic disease, kidney disease, vasculitis in a rheumatologic disease, liver failure, neuro-degenerative disorder, toxic injury (for example, spider bite, snake bite, toxin ingestion, chemotherapy), metastatic cancer, sepsis, eclampsia/HELLP syndrome, lupus, hemophagocytic lymphohistiocytosis (HLH), sickle cell disease (SCD) with vaso-occlusive cirises, veno-occlusive disease of liver (VOD or sinusoidal obstruction syndrome (SOS)), diffuse alveolar hemorrhage (DAH), idiopathic pneumonia syndrome (IPS), or combinations thereof.
Dependencies are inferred from the claim text.